STOCK TITAN
  1. Home
  2. GTHR

Genethera (GTHR) Stock Price, News & Analysis

GTHR OTC

Company Description

Genethera (OTC: GTHR) is classified in the biological product (except diagnostic) manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for GTHR, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
35.3M
Shares outstanding

Latest News

View All
+9.00%

GeneThera Inc. Enters into an exclusive real estate agreement with Cushman & Wakefield related to the ZIDAS project

+45.41%

GeneThera Inc. Expands Its Operation in the United Kingdom

+58.20%

GeneThera enters into a collaboration agreement with an International Construction Advisor Company to build a network of zoonotic diseases laboratory facilities

-20.93%

GeneThera’s Strategy for the Development of a Global Zoonotic Diseases Surveillance System Using Smart Testing Technology

+123.61%

GeneThera Technology Platform for Wastewater Testing: A More Effective Way to Control the COVID-19 Pandemic

covid-19

Genethera has 5 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include covid-19. View all GTHR news →

SEC Filings

View All

No SEC filings available for GTHR.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

GTHR Company Profile & Sector Positioning

Genethera (GTHR) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.